APA (7th ed.) Citation

Wu, M. Y., Carr, E. J., Harvey, R., Mears, H. V., Kjaer, S., Townsley, H., . . . Bauer, D. L. V. (2022). WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed. Lancet, 400(10369), 2193. https://doi.org/10.1016/S0140-6736(22)01938-9

Chicago Style (17th ed.) Citation

Wu, Mary Y., et al. "WHO's Therapeutics and COVID-19 Living Guideline on MAbs Needs to Be Reassessed." Lancet 400, no. 10369 (2022): 2193. https://doi.org/10.1016/S0140-6736(22)01938-9.

MLA (9th ed.) Citation

Wu, Mary Y., et al. "WHO's Therapeutics and COVID-19 Living Guideline on MAbs Needs to Be Reassessed." Lancet, vol. 400, no. 10369, 2022, p. 2193, https://doi.org/10.1016/S0140-6736(22)01938-9.